LPA and hyperlipoproteinemia: The results of these trials will enhance our knowledge in the field of Lp(a) and provide the foundation for the establishment of definitive indications for the management of hyperlipoproteinemia(a) in patients of different ages and ethnicities and with specific CVD risk factors or other health conditions.